Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	5/17/2005 2:42:27 PM
	Read Replies (1) of 946

Seems that CTIC isn't happy with the market's response to its ASCO presentation... +++++++++++++++++ Cell Therapeutics, Inc. to Review XYOTAX(TM) Data from ASCO Meeting 14:37 EDT Tuesday, May 17, 2005 SEATTLE, May 17 /PRNewswire-FirstCall/ -- On Wednesday, May 18, 2005, at 4:30 p.m. Eastern/1:30 p.m. Pacific members of Cell Therapeutics, Inc.'s (CTI) (Nasdaq and Nuovo Mercato: CTIC) management team will host a conference call to discuss data presented at the American Society of Clinical Oncology (ASCO) meeting. ASCO Review Conference Call Wednesday, May 18 4:30 p.m. Eastern/1:30 p.m. Pacific 1-800-500-0311 (US Participants) 1-719-457-2698 (International) Entry code: 2094919 Live audio webcast at cticseattle.com will be archived for post listening approximately two hours after call ends Call-back numbers for post listening 1-888-203-1112 1-719-457-0820 Entry code: 2094919 SOURCE Cell Therapeutics, Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next